WORLD CONGRESS

 
News Articles for WORLD CONGRESS top ^
Global auto supplier will help welcome 10,000 attendees to Motor City with exhibit, technology ride-and-drive, panel speakers and technical paper VAN BUREN TOWNSHIP, Mich.
Sign-up for Visteon Gearing Up to Showcase Intelligent Transportation Innovations at ITS World Congress in Detroit Sept. 7-11 investment picks
Global auto supplier to provide transportation insights through panels, technology exhibit, vehicle-to-vehicle ride-and-drive and technical paper VAN BUREN TOWNSHIP, Mich.
Sign-up for Visteon Presents a Deep Lineup of Activities at 2014 ITS World Congress in Detroit Sept. 7-11 investment picks
Forest Laboratories, Inc. (NYSE:FRX) today announced that data on the investigational drug cariprazine will be presented at the International College of Neuropsychopharmacology (CINP) 29th World Congress, scheduled June 22-26, 2014 in Vancouver, Canada.
Sign-up for Forest Laboratories, Inc. to Present Cariprazine Data at the International College of Neuropsychopharmacology World Congress investment picks
2014/9/3
Key Takeaways At Managed Services World Congress 2014, Comverse will deliver a key presentation analyzing recent managed services success stories from the Caribbean and other regions Comverse will demonstrate how its managed services approach yields quantifiable and repeatable advantages to service providers WAKEFIELD, Mass., Sept.
Sign-up for Comverse Case Studies at Managed Services World Congress: Effective Methodologies Deliver Outstanding Results investment picks
CAMBRIDGE, Mass., June 17, 2014 (GLOBE NEWSWIRE) -- Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK) today announced that results of the successful Phase 3 NAPOLI-1 study in metastatic pancreatic cancer will be communicated in an oral presentation at the European Society for Medical Oncology 16 th World Congress on Gastrointestinal Cancer (ESMO GI) held from June 25th to 28th, 2014 at The International Convention Center of Barcelona in Barcelona, Spain.
Sign-up for Merrimack Pharmaceuticals Announces Oral Presentation of Additional Data Results in Phase 3 NAPOLI-1 Study at the ESMO 16th World Congress on Gastrointestinal Cancer investment picks
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care, urology and surgery, will present its ARROW ® brand portfolio including PICCs and CVCs with Chlorag + ard® Technology, which provides antimicrobial and antithrombogenic protection, ARROW® VPS™ tip location system and the new EZ-IO ® Needle + Stabilizer Kit at the World Congress on Vascular Access in Berlin, Germany on June 18-20, 2014.
Sign-up for Teleflex to present at World Congress on Vascular Access 2014 (“WoCoVA”) in Berlin investment picks
2014/7/24
Phase II Open Label Trial results for prescription drug candidate, CaPre® to be presented on July 26, 2014 at 12:30 p.m. LAVAL, Quebec, July 24, 2014 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (" Acasti " or the " Corporation ") (Nasdaq:ACST) (TSX-V:APO), an emerging biopharmaceutical company focused on the research, development and commercialization of new krill oil-based forms of omega-3 phospholipid therapies for the treatment and prevention of certain cardiometabolic disorders, announces that it has been selected to give an oral presentation at the 19 th World Congress on Heart Disease.
Sign-up for Acasti Announces Oral Presentation on COLT Study Results at 19th World Congress on Heart Disease in Boston investment picks
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care, urology and surgery, will present for the first time at the 32 nd Annual World Congress of Endourology (WCE) and Shockwave Lithotripsy to be held in Taipei, Taiwan on September 3-7, 2014.
Sign-up for Teleflex to Present for the First Time at the 32nd Annual World Congress of Endourology and Shockwave Lithotripsy investment picks
MM-398 in combination with 5-fluorouracil and leucovorin shows statistically significant improvement in overall survival, progression free survival and overall response rate in patients with post-gemcitabine metastatic pancreatic cancer CAMBRIDGE, Mass., June 25, 2014 (GLOBE NEWSWIRE) -- Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK) today announced detailed results from NAPOLI-1, a large, randomized, three-arm Phase 3 study of MM-398, a nanoliposomal encapsulation of irinotecan, in patients with metastatic pancreatic cancer previously treated with gemcitabine-based therapy.
Sign-up for Merrimack Pharmaceuticals Presents Data From Phase 3 NAPOLI-1 Study at the ESMO 16th World Congress on Gastrointestinal Cancer investment picks
-- Results Validate "D" Shape Staple Used in Cardica's MicroCutter XCHANGE® 30 Enables 5-Millimeter and Potentially 3-Millimeter Surgical Stapler --
Sign-up for Cardica Announces Data Presentation At Amazing Technologies Session Of 14th Annual World Congress Of Endoscopic Surgery investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

WORLD CONGRESS
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: World Co  |  Next: World Cups